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PHA311 – Clinical Biochemistry 
DURATION 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
The examination has A and B sections  
 
Section A: Suggested Time: 90 minutes  
Answer ALL 7 questions on the booklet provided. Marks: 50  
 
Section B: Suggested Time: 90 minutes  
Answer ALL 3 questions in the booklet provided. Marks: 50 
 
 
Note that questions ARE NOT of equal value. 
Read ALL questions carefully.  
 
EXAM CONDITIONS 
You may begin writing from the commencement of the examination session.  The reading time indicated above is 
provided as a guide only. 
This is a CLOSED BOOK examination 
Any non-programmable calculator is permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 
No additional printed material is permitted 
 
 
1 x 20 Page Book 
1 x Scrap Paper 
Reference Information 
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Section A 
Short Essay Questions 
Total Number of Marks for this section: 50 Marks 
This section should be answered in the Answer Booklet provided. 
Marks for each question are indicated. 
Suggested Time allocation for Section A: 90 minutes 
 
Question 1  
Discuss the following components of liver function test. What information may they provide regarding 





(2x4= 8 Marks) 
 
Question 2  
A) Discuss the clinical importance of each component of the lipid test (total cholesterol, LDL, HDL and 
TG). 
(4 Marks) 
B) Comment on the following results of fasting serum lipid levels: 
I. Total cholesterol 6.3 mmol/L 
II. LDL   4.8 mmol/L 
III. HDL   1.3 mmol/L 
IV. Triglyceride  2.0 mmol/L 
(4 Marks) 
(Total: 8 Marks) 
 
 
 Semester 1, 2018 FINAL EXAMINATION Page 4 of 11  
PHA311 – Clinical Biochemistry 
 
THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM ANY EXAMINATION VENUE IN ANY 
CIRCUMSTANCE.  THIS EXAMINATION IS PRINTED DOUBLE-SIDED. 
 
 
Question 3  
Discuss any TWO (2) of the following biochemistry tests. What information can they provide regarding 
the health of an individual? Use examples to illustrate your answer. 
I. Troponin T 
II. Thyroid stimulating hormone (TSH) 
III. Serum creatinine 
(2x4= 8 Marks) 
 
 
Question 4  
Regarding diagnosis of diabetes mellitus or its complications, write short notes on ANY FOUR (4) of the 
following: 
I. Fasting blood glucose level (BGL) 
II. Oral Glucose Tolerance Test (OGTT) 
III. HbA1c 
IV. Serum insulin and c-peptide 
V. Urinary ketones 




A) For detection of acute cardiac injury, list THREE (3) most commonly used biomarkers. Draw a 
table/chart to show the approximate timeline of these markers. 
(3 Marks) 
B) Which of these biomarkers is the BEST in detecting acute cardiac injury and WHY? 
(3 Marks) 
(Total: 6 Marks) 
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Question 6  
Regarding a routine Full Blood Examination (FBE) report, discuss the importance of following 
parameters. Give TWO (2) clinical examples for an abnormal count/reading for each. 
I. Haematocrit 
II. MCV (Mean corpuscular volume) 
III. Reticulocyte count 
 (Total: 6 Marks) 
 
Question 7  
A new orally administered drug has been introduced in the hospital. It is unclear whether Therapeutic 
Drug Monitoring (TDM) is needed for this drug. 
A) What factors should be taken into consideration when addressing this question? 
(2 Marks) 
B) If you decide to monitor this drug, what are the key steps? You can use a diagram or flowchart to 
explain your answer. 
(4 Marks) 
(Total: 6 Marks) 
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Section B 
Case Study Based Questions 
Total Number of Marks for this section: 50 Marks 
This section should be answered in the Answer Booklet provided. 
Marks for each question are indicated. 
Suggested Time allocation for Section B: 90 minutes 
 
Case study 1 
A general practitioner was called to see a 21-year-old female student who had been complaining of a 
flu-like illness for 2 days. The illness had become worse, with symptoms of fever, vomiting, and 
abdominal tenderness in the right upper quadrant. On examining the patient, the doctor found she was 
pyrexial and jaundiced. The liver was enlarged and tender. On questioning her, the doctor found that 
she had recently returned from a long holiday in Asia. A sample of urine appeared dark, and bilirubin 
was present, and urobilinogen was increased. A blood sample was taken for liver function tests, the 
results of which were as follows:  
 
Plasma analysis Result Reference range 
[Albumin] (g/L) 40 32-45 
ALP activity (U/L) 190 40-125 
ALT activity (U/L) 560 10-40 
[Bilirubin, total] (µmo/L) 110 2-17 
GGT activity (U/L) 60 10-35 
 
Questions: 
1. What is the most likely diagnosis? Describe each component of LFTs (shown in the table) to 
support your diagnosis. (5 Marks) 
2. What can be the possible causes of such illness? (4 Marks) 
3. If you suspect a viral cause, which further tests would you perform? (6 Marks) 
 (Total: 15 Marks) 
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Case study 2 
A 30-year-old housewife attended her general practitioner. She had lost weight (6 kg in the previous 3 
months), was irritable and felt uncomfortable in the recent spell of hot weather. She was taking an 
oestrogen-containing oral contraceptive. On clinical examination, her palms were sweaty, and she had a 
fine tremor of the fingers when her arms were outstretched. The following results were reported for 
thyroid function tests: 
Plasma analysis Result Reference range 
[TSH] (mU/L) < 0.1 0.4-4.5 
[Free T4] (pmol/L) 20 10-27 
[Total T4] (nmol/L) 160 70-150 
[Free T3] (pmol/L) 20 3.0-9.0 
[Total T3] (nmol/L) 6 1.2-2.8 
 
Questions: 
1. What is the diagnosis in this patient, and on which results was this diagnosis based? (5 Marks) 
2. Which further study/studies would you like to perform, and why? (5 Marks) 
 
After establishing the diagnosis, patient was started on Carbimazole (15 mg three times/day). One 
month later, the lab results were as follows: 
Plasma analysis Result Reference range 
[TSH] (mU/L) < 0.1 0.4-4.5 
[Free T4] (pmol/L) < 5 10-27 
[Free T3] (pmol/L) 2.5 3.0-9.0 
 
Question: 
3. Comment on these results. Is this treatment working? If not, what will you suggest? (5 Marks) 
(Total: 15 Marks) 
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Case study 3 
Camilla, a 19-year-old pregnant insulin-dependent (type 1) diabetic patient, was admitted with a history 
of polyuria and thirst. She now felt ill and presented to hospital. There was a history of poor compliance 
with medical therapy. She was afebrile. The chest was clear. Circulation was adequate. Patient, 
however, was little disoriented. 
 
Biochemistry on admission 
Investigation  Result  Reference range  
Sodium  136 mmol/l  135-155 mmol/l 
Potassium  4.8 mmol/l  3.5-5.5 mmol/l 
Chloride 101 mmol/l  100-108 mmol/l 
Glucose 19.0 mmol/l  3.9-6.1 mmol/l (fasting) 
Urea 8.1 mmol/l  2.9-6.9 mmol/l 
Creatinine  0.09 mmol/l 0.05-0.13 mmol/l 
Bicarbonate  7.1 mmol/l  22-24 mmol/l  
Urinalysis    
Ketones 2+      Nil 
Glucose  4+      Nil  
  
Arterial blood gases were also collected on arrival 
 
Arterial Blood Gases  Reference range 
pH 7.26                          (7.35-7.45) 
pCO2 16 mmHg                  (40 mmHg) 
pO2 128 mmHg                (90-100 mmHg) 
HCO3
- 8 mmol/l                   (22-29 mmol/l) 
 
 
Camilla recovered with adequate management but compliance with diabetic therapy continued to be 




1. Discuss the laboratory findings in this case. (4 Marks) 
2. What is your diagnosis? Justify your diagnosis. (4 Marks) 
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3. Calculate the anion gap. Interpret the results. (4 Marks) 
4. What are the causes of high anion gap metabolic acidosis (HAGMA)? Which of these would fit 
with Camilla’s case? (4 Marks) 
5. Discuss the development of diabetic complications in Camilla’s case. (4 Marks) 
(Total: 20 Marks) 
 
 
END OF EXAM 
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Reference ranges for regular lab tests  
Urea and electrolytes (U&E)  
Na+ 135.0-145.0 mmol/L  
K+ 3.50-4.50 mmol/L (plasma) 3.8-4.9 mmol/L (serum)  
Cl- 95-110 mmol/L  
Urea 3.8-8.0 mmol/L  
Creatinine 60-100 µmol/L  
eGFR > 90 mL/min/1.73 m2  
Osmolality (serum) 275-295 mOsm/kg  
Anion gap 13-17 mEq/L  
 
Calcium, magnesium and phosphate (CMP)  
Ca2+ (total) 2.1-2.6 mmol/L  
Ca2+ (ionised) 1.16-1.3 mmol/L  
PO4
3- 0.8-1.5 mmol/L  
Mg2+ 0.8-1.0 mmol/L  
 
Arterial blood gas (ABG)  
pH 7.35-7.45  
pO2 80-110 mmHg  
pCO2 35-45 mmHg  
Bicarbonate (HCO3
-) 22-33 mmol/L  
 
Full blood examination (FBE)  
Hb 140-174 (male); 120-160 (female) g/L  
RCC 4.50-5.50 (male); 4.0-5.0 (female) x1012 /L  
Haematocrit 0.42-0.52 or 42-52 % (male); 0.36-0.48 or 36-48% (female)  
MCV 80.0-100.0 fL  
RDW 11.5-14.5 %  
Platelets 150-450 (x109 /L)  
WCC 4.0-11.0 (x109 /L)  
Neutrophil 40-80%; or 2.0-7.5 (x109 /L)  
Lymphocytes 20-40%; or 1.5-4.0 (x109 /L)  
Monocytes 2-10%; or 0.2-0.8 (x109 /L)  
Eosinophils 1-6%; or 0.0-0.4 (x109 /L)  
Basophils <2%; or 0.0-0.1 (x109 /L) 
 
Liver function test (LFT)  
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ALT <30 U/L  
AST <40 U/L  
ALP 30-100 U/L  
GGT <30 U/L (female); <50 U/L (male)  
Bilirubin (total) <20 micromol/L  
Bilirubin 
(conjugated) 
<4.0 micromol/L  
Albumin 32-45 g/L  
Total protein 63-80 g/L  
Pancreatic lipase 8 – 78 U/L  
 
Thyroid function test (TFT)  
TSH 0.4-5.0 mU/L  
T4 (free) 10-25 pmol/L  
T3 (free) 3.0-6.5 pmol/L  
 
Carbohydrate metabolism  
BSL (random) 3.0-7.7 mmol/L  
BSL (fasting) 3.0-5.5 mmol/L  
HbA1c (non-DM)  4.3-5.7% (NGSP); 23-39 mmol/mol (IFCC)  
HbA1c (DM) 
therapeutic target 
<7% *  
 
Fasting lipid biochemistry  
Total cholesterol  <5.5 mmol/L  
LDL 2-3.4 mmol/L  
HDL  >1 mmol/L  
Non-HDL cholesterol  <2.5 mmol/L  
TG  <1.7 mmol/L  
 
Others  
Troponin T  <0.01 μg/L  
CRP <3 mg/L  
D-dimer <500 μg/L  
BNP <20 nmol/L 
 
